in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (Yesterday)
New Risk Assessment app brings data together - read about our new app here: https://t.co/aIL7uFPllV …… https://t.co/cJrkj8lC70
Douglas Connect (6 days ago)
InnovationWell comes to Basel, OpenRiskNet launches its new website, read the November 2018 Douglas Connect Newslet… https://t.co/VJ4Eg3pH9a
Douglas Connect (2 weeks ago)
Could modern information technology provide the missing link to make full use of the hundreds of thousands of compo… https://t.co/2jop0bnxmA
Douglas Connect (4 weeks ago)
RT @LucianFarcal: Learning on EU open #PM2 methodology @EURACADEMY projects implementation process, benefits for the organisation and socie…
Douglas Connect (4 weeks ago)
Exploring AI and Machine Learning Approaches to Precision Medicine and Healthcare - Webinar 2:30-3:30 pm EDT, Thurs… https://t.co/h8z8NSpxB8

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com